| " Addition of fluoxetine to treatment of schizophrenic patients": Reply. DC Goff, AW Brotman, S McCormick, M Waites American Psychiatric Assn, 1991 | | 1991 |
| " Is anything consistent over time?": Reply. DC Goff Lippincott Williams & Wilkins, 1993 | | 1993 |
| " Smoking cessation in schizophrenia": Reply. AE Evins, C Cather, T Deckersbach, O Freudenreich, DC Henderson, ... Lippincott Williams & Wilkins, 2007 | | 2007 |
| " The long-term effects of antipsychotic medication on clinical course in schizophrenia": Correction. DC Goff, P Falkai, WW Fleischhacker, RR Girgis, RM Kahn, H Uchida, ... American Psychiatric Assn, 2017 | | 2017 |
| " Treatment of schizophrenia with anticholinergic medications": Dr. Goff replies. D Goff American Psychiatric Assn, 1995 | | 1995 |
| 117. Biomarker Assessment of Dose Dependent Target Engagement of mGluR-2, 3 Partial Agonist for Schizophrenia Treatment J Lieberman, D Goff, S Marder, A Lahti, D Javitt, J Kantrowitz, R Girgis, ... Biological Psychiatry 85 (10), S49, 2019 | | 2019 |
| 153. Abnormalities in thalamus and prefrontal cortex during episodic object recognition in schizophrenia S Heckers, T Curran, D Goff, SL Rauch, AJ Fischman, NM Alpert, ... Biological Psychiatry 47 (8), S46, 2000 | | 2000 |
| 42 Antipsychotic Drugs O Freudenreich, DC Goff, DC Henderson | | |
| 8 Glutamate Receptors in DC Goff Neurotransmitter Receptors in Actions of Antipsychotic Medications, 121, 2000 | | 2000 |
| A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ... Journal of clinical psychopharmacology 27 (4), 380-386, 2007 | 210 | 2007 |
| A 23-year-old man with schizophrenia DC Goff JAMA 287 (24), 3249-3257, 2002 | 8 | 2002 |
| A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole HE Brown, AW Flaherty, DC Goff, O Freudenreich The Primary Care Companion for CNS Disorders 13 (6), 26760, 2011 | 5 | 2011 |
| A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls DC Goff, LM Sullivan, JP McEvoy, JM Meyer, HA Nasrallah, GL Daumit, ... Schizophrenia research 80 (1), 45-53, 2005 | 716 | 2005 |
| A comparison of the effects of quetiapine and olanzapine on glucose metabolism in patients with schizophrenia D Henderson, PM Copeland, CP Borba, DD Nguyen, AE Evins, H Zhang, ... EUROPEAN NEUROPSYCHOPHARMACOLOGY 15, S494-S495, 2005 | | 2005 |
| A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ... Journal of clinical psychopharmacology 25 (3), 218-225, 2005 | 252 | 2005 |
| A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain DC Henderson, PM Copeland, TB Daley, CP Borba, C Cather, ... American Journal of Psychiatry 162 (5), 954-962, 2005 | 174 | 2005 |
| A double‐blind, placebo‐controlled trial of rosiglitazone for clozapine‐induced glucose metabolism impairment in patients with schizophrenia DC Henderson, X Fan, B Sharma, PM Copeland, CP Borba, R Boxill, ... Acta psychiatrica scandinavica 119 (6), 457-465, 2009 | 49 | 2009 |
| A double‐blind, placebo‐controlled trial of sibutramine for clozapine‐associated weight gain DC Henderson, X Fan, PM Copeland, CP Borba, TB Daley, DD Nguyen, ... Acta Psychiatrica Scandinavica 115 (2), 101-105, 2007 | 75 | 2007 |
| A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia DS Manoach, MS Cain, MG Vangel, A Khurana, DC Goff, R Stickgold Biological psychiatry 56 (12), 951-956, 2004 | 131 | 2004 |
| A hypomethylating variant of MTHFR, 677C> T, blunts the neural response to errors in patients with schizophrenia and healthy individuals JL Roffman, AZ Nitenson, Y Agam, M Isom, JS Friedman, KA Dyckman, ... PloS one 6 (9), e25253, 2011 | 41 | 2011 |
